National Heart, Lung, and Blood Institute Notice of Charter Renewal, 44134 [2023-14532]
Download as PDF
<![CDATA[
44134
Federal Register / Vol. 88, No. 131 / Tuesday, July 11, 2023 / Notices
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel RFA DK22–018
Human Islet Research Network (HIRN)
Pancreas Knowledgebase Program (PanKbase)
(U24—Clinical Trial Not Allowed).
Date: August 3, 2023.
Time: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, NIDDK/Scientific
Review Branch, National Institutes of Health,
6707 Democracy Blvd., Room 7013,
Bethesda, MD 20892, 301–594–2242,
ann.jerkins@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: July 5, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–14514 Filed 7–10–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Retromers in
Alzheimer’s Disease.
Date: July 26, 2023.
Time: 3:00 p.m. to 6:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dario Dieguez, Ph.D.,
Scientific Review Officer, Scientific Review
VerDate Sep<11>2014
17:25 Jul 10, 2023
Jkt 259001
Branch, National Institutes of Health,
National Institute on Aging, Bethesda, MD
20814, (301) 827–3101, dario.dieguez@
nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: July 5, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–14511 Filed 7–10–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute Notice of Charter Renewal
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the Sickle Cell
Diseases Advisory Committee was
renewed for an additional two-year
period on June 30, 2023.
It is determined that the Sickle Cell
Diseases Advisory Committee is in the
public interest in connection with the
performance of duties imposed on the
National Institutes of Health by law, and
that these duties can best be performed
through the advice and counsel of this
group.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail Stop Code 4875), Telephone (301)
496–2123, or harriscl@mail.nih.gov.
Dated: July 5, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–14532 Filed 7–10–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Tribal Technical Advisory Committee;
Notice of Meeting
Substance Abuse and Mental
Health Services Administration
(SAMHSA).
AGENCY:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Notice of Advisory Committee
Meeting and Tribal Consultation.
ACTION:
Notice is given for the August
29, 2023, virtual meeting of SAMHSA’s
Tribal Technical Advisory Committee
(TTAC). TTAC meetings are exclusively
between federal officials and elected
officials of Tribal governments (or their
designated employees) to exchange
views, information, or advice related to
the management or implementation of
SAMHSA programs. The public may
attend but are not allowed to participate
in the meeting. Immediately following
the TTAC meeting, SAMHSA will host
American Indian and Alaska Native (AI/
AN) Federally Recognized Tribes for a
virtual Tribal Consultation session on
the BEHAVIORAL HEALTH AND
SUBSTANCE USE DISORDER
RESOURCES FOR NATIVE
AMERICANS PROGRAM.
DATES: The virtual SAMHSA TTAC
Meeting will be held on August 29,
2023, from 1:00 p.m. to 4:00 p.m. EDT.
Registration is required: https://
snacregister.samhsa.gov. You must
register to obtain the call-in number,
access code, and/or web access link or
request special accommodations for
those with disabilities.
The virtual Tribal Consultation will
be held on August 29, 2023, at 4:00 p.m.
EDT. Registration is required: https://
www.zoomgov.com/meeting/register/
vJItfuitqDIvGJb7z8G5vUTNjXjFDxOG8U. Instructions
to access the Zoom virtual consultation
will be provided in the above link
following registration.
FOR FURTHER INFORMATION CONTACT:
CAPT Karen Hearod, MSW, LCSW,
Director, Office of Tribal Affairs and
Policy, Substance Abuse and Mental
Health Services Administration,
Telephone: (202)-868–9931, Email:
otap@samhsa.hhs.gov
SUPPLEMENTARY INFORMATION: The
SAMHSA TTAC meeting is open to the
public. An agenda with call-in
information will be posted on the
SAMHSA website prior to the meeting
at: https://www.samhsa.gov/about-us/
advisory-councils/meetings. This
meeting will include, but is not limited
to, remarks from the Assistant Secretary
for Mental Health and Substance Use;
updates on SAMHSA priorities; follow
up on topics related to the previous
TTAC meetings; and council
discussions. Meeting information and a
roster of TTAC members may be
obtained either by accessing the
SAMHSA Council’s website at https://
www.samhsa.gov/about-us/advisorycouncils/, or by contacting Karen
Hearod.
SUMMARY:
E:\FR\FM\11JYN1.SGM
11JYN1
]]>Agencies
[Federal Register Volume 88, Number 131 (Tuesday, July 11, 2023)]
[Notices]
[Page 44134]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-14532]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute Notice of Charter
Renewal
In accordance with Title 41 of the U.S. Code of Federal
Regulations, Section 102-3.65(a), notice is hereby given that the
Charter for the Sickle Cell Diseases Advisory Committee was renewed for
an additional two-year period on June 30, 2023.
It is determined that the Sickle Cell Diseases Advisory Committee
is in the public interest in connection with the performance of duties
imposed on the National Institutes of Health by law, and that these
duties can best be performed through the advice and counsel of this
group.
Inquiries may be directed to Claire Harris, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail Stop Code 4875), Telephone (301) 496-2123, or
[email protected].
Dated: July 5, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2023-14532 Filed 7-10-23; 8:45 am]
BILLING CODE 4140-01-P
